{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:25:08Z","timestamp":1793053508069,"version":"4.5.0"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.phrs.2025.107927","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T14:23:46Z","timestamp":1756045426000},"page":"107927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Glucagon-like peptide-1 receptor agonists and muscle mass effects"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0043-9051","authenticated-orcid":false,"given":"Alexandr","family":"Ceasovschih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5567-8746","authenticated-orcid":false,"given":"Andreea","family":"Asaftei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7083-2692","authenticated-orcid":false,"given":"Stanislav","family":"Kotlyarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9506-8312","authenticated-orcid":false,"given":"Hana","family":"Bartu\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1550-0262","authenticated-orcid":false,"given":"Anastasia","family":"Balta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victorita","family":"Sorodoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurentiu","family":"Sorodoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00223-014-9915-y","article-title":"Skeletal muscle: a brief review of structure and function","volume":"96","author":"Frontera","year":"2015","journal-title":"Calcif. Tissue Int"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40520-016-0704-5","article-title":"SPRINTT consortium. Sarcopenia: an overview","volume":"29","author":"Marzetti","year":"2017","journal-title":"Aging Clin. Exp. Res."},{"issue":"7","key":"10.1016\/j.phrs.2025.107927_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","article-title":"Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"34","author":"F\u00fclster","year":"2013","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.phrs.2025.107927_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ajcn\/70.6.1025","article-title":"Longitudinal changes in adult fat-free mass: influence of body weight","volume":"70","author":"Forbes","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2025.107927_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-12-800101-1.00005-3","article-title":"Enhanced skeletal muscle for effective glucose homeostasis","volume":"121","author":"Yang","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107927_bib6","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3390\/nu13072473","article-title":"Weight loss strategies and the risk of skeletal muscle mass loss","volume":"13","author":"McCarthy","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/dmrr.414","article-title":"The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake","volume":"20","author":"Clerk","year":"2004","journal-title":"Diabetes Metab. Res Rev."},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1440-1681.2005.04188.x","article-title":"Active role for the vasculature in the delivery of insulin to skeletal muscle","volume":"32","author":"Vincent","year":"2005","journal-title":"Clin. Exp. Pharm. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/1440-1681.12688","article-title":"Regulation of microvascular flow and metabolism: an overview","volume":"44","author":"Keske","year":"2017","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"10.1016\/j.phrs.2025.107927_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fnut.2019.00087","article-title":"Obesity alters the muscle protein synthetic response to nutrition and exercise","volume":"6","author":"Beals","year":"2019","journal-title":"Front. Nutr."},{"key":"10.1016\/j.phrs.2025.107927_bib11","article-title":"GLP-1 receptor agonists for the treatment of obesity: role as a promising approach","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"\"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2025.107927_bib13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting","volume":"48","author":"K\u00f6rner","year":"2007","journal-title":"J. Nucl. Med."},{"issue":"9","key":"10.1016\/j.phrs.2025.107927_bib14","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1021\/pr400527q","article-title":"\"Glucagon-Like Peptide-1 protects human islets against Cytokine-Mediated \u03b2-Cell dysfunction and death: a proteomic study of the pathways involved","volume":"12","author":"Rondas","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.phrs.2025.107927_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajem.2024.01.010","article-title":"GLP-1 agonists: a review for emergency clinicians","volume":"78","author":"Long","year":"2024","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.phrs.2025.107927_bib16","series-title":"Compare and contrast the glucagon-like peptide-1 receptor agonists (GLP1RAs)","author":"Latif","year":"2021"},{"key":"10.1016\/j.phrs.2025.107927_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc24-1678","article-title":"Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials","volume":"48","author":"Wong","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2025.107927_bib18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/oby.24002","article-title":"Efficacy and safety of tirzepatide, GLP -1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta-analysis","volume":"32","author":"Pan","year":"2024","journal-title":"Obesity"},{"key":"10.1016\/j.phrs.2025.107927_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide -1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib20","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae155","article-title":"Physiology and pharmacology of effects of GLP-1-based therapies on gastric, biliary and intestinal motility","volume":"166","author":"Jalleh","year":"2024","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.phrs.2025.107927_bib21","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2337\/db14-0849","article-title":"GLP-1 receptor activation modulates Appetite- and Reward-Related brain areas in humans","volume":"63","author":"van Bloemendaal","year":"2014","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.phrs.2025.107927_bib22","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1111\/bcp.14855","article-title":"Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: a meta-analysis of randomized controlled trials","volume":"87","author":"Simental-Mend\u00eda","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2025.107927_bib23","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/jdi.13775","article-title":"Effect of glucagon-like peptide-1 receptor agonists on fat distribution in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"13","author":"Duan","year":"2022","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.phrs.2025.107927_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fendo.2022.1099451","article-title":"Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: a retrospective, cohort study (Sema-MiDiab01)","volume":"13","author":"Berra","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phrs.2025.107927_bib25","doi-asserted-by":"crossref","first-page":"2S3","DOI":"10.1016\/S1262-3636(17)30067-8","article-title":"After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists?","volume":"43","author":"Verg\u00e8s","year":"2017","journal-title":"Diabetes Metabolism 43"},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib26","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/en.2018-00004","article-title":"\"GLP-1 receptor expression within the human heart","volume":"159","author":"Baggio","year":"2018","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib27","doi-asserted-by":"crossref","first-page":"10644","DOI":"10.1038\/s41598-018-28849-1","article-title":"\"Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity","volume":"8","author":"Kimura","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.phrs.2025.107927_bib28","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cvr\/cvae120","article-title":"\"Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node.\"","volume":"120","author":"Lubberding","year":"2024","journal-title":"Cardiovasc. Res."},{"issue":"18","key":"10.1016\/j.phrs.2025.107927_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/JAHA.118.009379","article-title":"Liraglutide treatment reduces endothelial endoplasmic reticulum stress and insulin resistance in patients with diabetes mellitus","volume":"7","author":"Breton-Romero","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.phrs.2025.107927_bib30","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/ATVBAHA.115.305447","article-title":"\"GLP-1 receptor agonist exenatide increases capillary perfusion independent of nitric oxide in healthy overweight men","volume":"35","author":"Smits","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6706","key":"10.1016\/j.phrs.2025.107927_bib31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.adn4128","article-title":"The benefits of GLP-1 drugs beyond obesity","volume":"385","author":"Drucker","year":"2024","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.phrs.2025.107927_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3892\/ijmm.2025.5515","article-title":"Role of GLP 1 receptor agonists in sepsis and their therapeutic potential in sepsis induced muscle atrophy (Review)","volume":"55","author":"Zhao","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41374-018-0170-0","article-title":"Glucagon-like peptide-1 receptor activation alleviates lipopolysaccharide-induced acute lung injury in mice via maintenance of endothelial barrier function","volume":"99","author":"Xu","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/j.phrs.2025.107927_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/0300060521992981","article-title":"GLP-1 alleviates NLRP3 inflammasome-dependent inflammation in perivascular adipose tissue by inhibiting the NF-\u03baB signalling pathway","volume":"49","author":"Chen","year":"2021","journal-title":"J. Int. Med Res"},{"key":"10.1016\/j.phrs.2025.107927_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.phrs.2025.107927_bib38","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/hep.23569","article-title":"Glucagon-Like Peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosisin vitroby modulating elements of the insulin signaling pathway","volume":"51","author":"Gupta","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00018-024-05507-6","article-title":"GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cells","volume":"81","author":"da Silva Lima","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib40","doi-asserted-by":"crossref","first-page":"22063","DOI":"10.1038\/s41598-021-01663-y","article-title":"A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)","volume":"11","author":"Ghosal","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2015.08.038","article-title":"Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis","volume":"64","author":"Armstrong","year":"2016","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.phrs.2025.107927_bib42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A Placebo-Controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2025.107927_bib43","first-page":"1","article-title":"GLP-1-based therapies for diabetes, obesity and beyond","author":"Drucker","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.phrs.2025.107927_bib44","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.tem.2023.07.006","article-title":"Cytokines and exosomal miRNAs in skeletal muscle-adipose crosstalk","volume":"34","author":"Guo","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s13105-023-00969-x","article-title":"Exercise-derived skeletal myogenic exosomes as mediators of intercellular crosstalk: a major player in health, disease, and exercise","volume":"79","author":"Ni","year":"2023","journal-title":"J. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib46","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201902468RR","article-title":"Muscle-derived exosomes encapsulate myomirs and are involved in local skeletal muscle tissue communication","volume":"35","author":"Mytidou","year":"2021","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib47","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1038\/s41467-021-26095-0","article-title":"Endurance exercise training-responsive miR-19b-3p improves skeletal muscle glucose metabolism","volume":"12","author":"Massart","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib48","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41598-025-85174-0","article-title":"Exercise promotes peripheral glycolysis in skeletal muscle through miR-204 induction via the HIF-1\u03b1 pathway","volume":"15","author":"Lee","year":"2025","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.phrs.2025.107927_bib49","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1002\/2211-5463.13504","article-title":"Myoblast-derived exosomes promote the repair and regeneration of injured skeletal muscle in mice","volume":"12","author":"Ji","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.phrs.2025.107927_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2015.12.018","article-title":"Exosomes from differentiating human skeletal muscle cells trigger myogenesis of stem cells and provide biochemical cues for skeletal muscle regeneration","volume":"222","author":"Choi","year":"2016","journal-title":"J. Control Release"},{"issue":"20","key":"10.1016\/j.phrs.2025.107927_bib51","doi-asserted-by":"crossref","first-page":"10877","DOI":"10.3390\/ijms252010877","article-title":"Recent advances of exosomes derived from skeletal muscle and crosstalk with other tissues","volume":"25","author":"Luo","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2025.107927_bib52","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1113\/EP090062","article-title":"Obesity and exercise training alter inflammatory pathway skeletal muscle small extracellular vesicle microRNAs","volume":"107","author":"Sullivan","year":"2022","journal-title":"Exp. Physiol."},{"issue":"22","key":"10.1016\/j.phrs.2025.107927_bib53","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1113\/JP282663","article-title":"Circulating exosome-like vesicle and skeletal muscle microRNAs are altered with age and resistance training","volume":"601","author":"Xhuti","year":"2023","journal-title":"J. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107927_bib54","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/jcsm.13364","article-title":"The role of extracellular vesicles in skeletal muscle wasting","volume":"14","author":"Zhang","year":"2023","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"18","key":"10.1016\/j.phrs.2025.107927_bib55","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.3390\/nu16183097","article-title":"Functional role of extracellular vesicles in skeletal muscle physiology and sarcopenia: the importance of physical exercise and nutrition","volume":"16","author":"Lombardo","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2025.107927_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.567881","article-title":"Muscle-Organ crosstalk: focus on immunometabolism","volume":"11","author":"Bay","year":"2020","journal-title":"Front. Physiol."},{"issue":"23","key":"10.1016\/j.phrs.2025.107927_bib57","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.3390\/nu16234032","article-title":"Myokines and microbiota: new perspectives in the endocrine Muscle-Gut axis","volume":"16","author":"Saponaro","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI88880","article-title":"Skeletal muscle inflammation and insulin resistance in obesity","volume":"127","author":"Wu","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2025.107927_bib59","first-page":"6","article-title":"Interleukin-6 in acute exercise and training: what is the biological relevance?","volume":"12","author":"Fischer","year":"2006","journal-title":"Exerc Immunol. Rev."},{"key":"10.1016\/j.phrs.2025.107927_bib60","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0548","article-title":"The role of PANDER and its interplay with IL-6 in the regulation of GLP-1 secretion","volume":"13","author":"Li","year":"2024","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.phrs.2025.107927_bib61","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00125-019-05045-y","article-title":"GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study","volume":"63","author":"Ellingsgaard","year":"2020","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib62","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/molecules27031118","article-title":"FNDC5\/Irisin: physiology and pathophysiology","volume":"27","author":"Waseem","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2025.107927_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101829","article-title":"Adipose-muscle crosstalk in age-related metabolic disorders: the emerging roles of adipo-myokines","volume":"84","author":"Fang","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.phrs.2025.107927_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110715","article-title":"If my muscle could talk: myokines as a biomarker of frailty","volume":"127","author":"Coelho-Junior","year":"2019","journal-title":"Exp. Gerontol."},{"issue":"7","key":"10.1016\/j.phrs.2025.107927_bib65","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1249\/01.MSS.0000074670.03001.98","article-title":"Weight loss and exercise: implications for muscle lipid metabolism and insulin action","volume":"36","author":"Berggren","year":"2004","journal-title":"Med. Sci. Sports Exerc."},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107927_bib66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2013.06.018","article-title":"The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging","volume":"379","author":"Toledo","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"issue":"8","key":"10.1016\/j.phrs.2025.107927_bib67","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1111\/dom.15637","article-title":"Obesity-induced tissue alterations resist weight loss: a mechanistic review","volume":"26","author":"Della Guardia","year":"2024","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3803\/EnM.2020.35.1.1","article-title":"Impact of skeletal muscle mass on metabolic health","volume":"35","author":"Kim","year":"2020","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2025.107927_bib69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fendo.2020.00332","article-title":"Health consequences of sarcopenic obesity: a narrative review","volume":"11","author":"Roh","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib70","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/oby.23374","article-title":"Beyond appetite regulation: targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss","volume":"30","author":"Christoffersen","year":"2022","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib71","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12937-021-00688-3","article-title":"The effect of additional protein on lean body mass preservation in post-bariatric surgery patients: a systematic review","volume":"20","author":"Romeijn","year":"2021","journal-title":"Nutr. J."},{"key":"10.1016\/j.phrs.2025.107927_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2021.103220","article-title":"W. The effect of protein supplements on weight loss, body composition, protein status, and micronutrients post laparoscopic sleeve gastrectomy (LSG): a randomised controlled trial (RCT)","volume":"74","author":"Alshamari","year":"2022","journal-title":"Ann. Med. Surg."},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib73","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.clnu.2024.01.031","article-title":"The effects of protein intake higher than the recommended value on body composition changes after bariatric surgery: a meta-analysis of randomized controlled trials","volume":"43","author":"Golzarand","year":"2024","journal-title":"Clin. Nutr."},{"issue":"12","key":"10.1016\/j.phrs.2025.107927_bib74","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1589\/jpts.27.3787","article-title":"Weight loss May be a better approach for managing musculoskeletal conditions than increasing muscle mass and strength","volume":"27","author":"Kim","year":"2015","journal-title":"J. Phys. Ther. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107927_bib75","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13444","article-title":"Association of muscle fiber type with measures of obesity: a systematic review","volume":"23","author":"Damer","year":"2022","journal-title":"Obes. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib76","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cmet.2021.03.020","article-title":"The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia","volume":"33","author":"Sylow","year":"2021","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib77","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2337\/db14-0590","article-title":"Human muscle fiber type-specific insulin signaling: impact of obesity and type 2 diabetes","volume":"64","author":"Albers","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109221","article-title":"Fat infiltration in skeletal muscle: influential triggers and regulatory mechanism","volume":"27","author":"Wang","year":"2024","journal-title":"Iscience"},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1152\/japplphysiol.00797.2019","article-title":"Impact of exercise training status on the fiber type-specific abundance of proteins regulating intramuscular lipid metabolism","volume":"128","author":"Shaw","year":"2020","journal-title":"J. Appl. Physiol."},{"issue":"9","key":"10.1016\/j.phrs.2025.107927_bib80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/sports9090127","article-title":"Muscle fiber type transitions with exercise training: shifting perspectives","volume":"9","author":"Plotkin","year":"2021","journal-title":"Sports"},{"issue":"109","key":"10.1016\/j.phrs.2025.107927_bib81","doi-asserted-by":"crossref","first-page":"20150365","DOI":"10.1098\/rsif.2015.0365","article-title":"The effect of intramuscular fat on skeletal muscle mechanics: implications for the elderly and obese","volume":"12","author":"Rahemi","year":"2015","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.phrs.2025.107927_bib82","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae827","article-title":"Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes","author":"Souza","year":"2025","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.phrs.2025.107927_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221366","article-title":"Aging- and obesity-related peri-muscular adipose tissue accelerates muscle atrophy","volume":"14","author":"Zhu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2025.107927_bib84","article-title":"Intermuscular adipose tissue in obesity and related disorders: cellular origins, biological characteristics and regulatory mechanisms","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107927_bib85","first-page":"730","article-title":"Skeletal muscle and fiber type-specific intramyocellular lipid accumulation in obese mice","volume":"21","author":"Umek","year":"2021","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S0029665107005277","article-title":"High-fat diet, muscular lipotoxicity and insulin resistance","volume":"66","author":"Schrauwen","year":"2007","journal-title":"Proc. Nutr. Soc."},{"issue":"5","key":"10.1016\/j.phrs.2025.107927_bib87","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00424-005-1509-0","article-title":"Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state","volume":"451","author":"van Loon","year":"2006","journal-title":"Pflug. Arch."},{"issue":"12","key":"10.1016\/j.phrs.2025.107927_bib88","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/db24-0083","article-title":"Effect of weight loss on skeletal muscle bioactive lipids in people with obesity and type 2 diabetes","volume":"73","author":"Petersen","year":"2024","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib89","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/oby.20615","article-title":"Pro-inflammatory macrophages increase in skeletal muscle of high fat-fed mice and correlate with metabolic risk markers in humans","volume":"22","author":"Fink","year":"2014","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib90","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/biom15010020","article-title":"The change of skeletal muscle caused by inflammation in obesity as the key path to fibrosis: thoughts on mechanisms and intervention strategies","volume":"15","author":"Li","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib91","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41598-018-37187-1","article-title":"Human skeletal muscle macrophages increase following cycle training and are associated with adaptations that May facilitate growth","volume":"9","author":"Walton","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2025.107927_bib92","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1152\/ajpendo.00553.2012","article-title":"Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications","volume":"304","author":"Pillon","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"14","key":"10.1016\/j.phrs.2025.107927_bib93","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.3390\/ijms241411467","article-title":"The role of macrophage populations in skeletal muscle insulin sensitivity: current understanding and implications","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2025.107927_bib94","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/cells12091214","article-title":"Macrophage involvement in Aging-Associated skeletal muscle regeneration","volume":"12","author":"Cui","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107927_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.948819","article-title":"Immunometabolism of macrophages regulates skeletal muscle regeneration","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib96","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12979-024-00458-9","article-title":"Harnessing immunomodulation to combat sarcopenia: current insights and possible approaches","volume":"21","author":"Zhang","year":"2024","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.phrs.2025.107927_bib97","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semcancer.2025.02.012","article-title":"Immunosenescence in skeletal muscle: the role-play in cancer cachexia chessboard","volume":"111","author":"Giovarelli","year":"2025","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.phrs.2025.107927_bib98","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ebiom.2019.10.034","article-title":"Skeletal muscle as potential central link between sarcopenia and immune senescence","volume":"49","author":"Nelke","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2025.107927_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.orcp.2025.01.009","article-title":"Effects of liraglutide on body composition in people living with obesity or overweight: a systematic review","volume":"19","author":"Schmidt","year":"2025","journal-title":"Obes. Res. Clin. Pr."},{"key":"10.1016\/j.phrs.2025.107927_bib101","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/2050-6511-14-53","article-title":"Lean body mass: the development and validation of prediction equations in healthy adults","volume":"14","author":"Yu","year":"2013","journal-title":"BMC Pharm. Toxicol."},{"issue":"12","key":"10.1016\/j.phrs.2025.107927_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2024.100335","article-title":"Are lean body mass and Fat-Free mass the same or different body components? A critical perspective","volume":"15","author":"Heymsfield","year":"2024","journal-title":"Adv. Nutr."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib103","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajpa.23398","article-title":"Relationship between body mass, lean mass, fat mass, and limb bone cross-sectional geometry: implications for estimating body mass and physique from the skeleton","volume":"166","author":"Pomeroy","year":"2018","journal-title":"Am. J. Phys. Anthr."},{"issue":"11","key":"10.1016\/j.phrs.2025.107927_bib104","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae164","article-title":"Fundamental body composition principles provide context for Fat-Free and skeletal muscle loss with GLP-1 RA treatments","volume":"8","author":"Tinsley","year":"2024","journal-title":"J. Endocr. Soc."},{"issue":"9","key":"10.1016\/j.phrs.2025.107927_bib105","first-page":"561","article-title":"Physiologic studies pertaining to deep sea diving and aviation, especially in relation to the fat content and composition of the body: the harvey lecture","volume":"18","author":"Behnke","year":"1942","journal-title":"Bull. N. Y Acad. Med."},{"issue":"6","key":"10.1016\/j.phrs.2025.107927_bib106","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3945\/ajcn.113.078576","article-title":"A population-based approach to define body-composition phenotypes","volume":"99","author":"Prado","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib107","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.clnu.2020.10.021","article-title":"Estimation of skeletal muscle mass by bioimpedance and differences among skeletal muscle mass indices for assessing sarcopenia","volume":"40","author":"Xu","year":"2021","journal-title":"Clin. Nutr."},{"issue":"22","key":"10.1016\/j.phrs.2025.107927_bib108","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.3390\/nu16223897","article-title":"Appendicular skeletal muscle mass (ASMM) and Fat-Free mass (FFM) DXA-BIA estimations for the early identification of Sarcopenia\/Low muscle mass in Middle-Aged women","volume":"16","author":"Moroni","year":"2024","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.phrs.2025.107927_bib109","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1007\/s00261-021-03294-3","article-title":"Sarcopenia: imaging assessment and clinical application","volume":"47","author":"Chianca","year":"2022","journal-title":"Abdom. Radio."},{"issue":"8","key":"10.1016\/j.phrs.2025.107927_bib110","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.21037\/qims.2020.03.02","article-title":"Body composition with dual energy X-ray absorptiometry: from basics to new tools","volume":"10","author":"Messina","year":"2020","journal-title":"Quant. Imaging Med. Surg."},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib111","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11547-022-01450-3","article-title":"Sarcopenia: how to measure, when and why","volume":"127","author":"Tagliafico","year":"2022","journal-title":"Radio. Med."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s42058-024-00142-3","article-title":"Application of imaging methods and the latest progress in sarcopenia","volume":"7","author":"Li","year":"2024","journal-title":"Chin. J. Acad. Radio."},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib113","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cardfail.2024.01.005","article-title":"Malnutrition and sarcopenia as reasons for caution with GLP-1 receptor agonist use in HFpEF","volume":"30","author":"Driggin","year":"2024","journal-title":"J. Card. Fail"},{"issue":"ement_1","key":"10.1016\/j.phrs.2025.107927_bib114","article-title":"Novel approach to sarcopenia in diabetic patients treated with GLP-1 receptor agonists (GLP-1RA)","volume":"67","author":"Ikejima","year":"2018","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/nu16030436","article-title":"Diagnostic criteria and measurement techniques of sarcopenia: a critical evaluation of the Up-to-Date evidence","volume":"16","author":"Voulgaridou","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2025.107927_bib116","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fphys.2012.00260","article-title":"Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review","volume":"3","author":"Mitchell","year":"2012","journal-title":"Front Physiol."},{"issue":"7","key":"10.1016\/j.phrs.2025.107927_bib117","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1753-4887.2010.00298.x","article-title":"A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity","volume":"68","author":"Weinheimer","year":"2010","journal-title":"Nutr. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib118","first-page":"16","article-title":"Sarcopenia: revised european consensus on definition and diagnosis. Age ageing","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Errat.. Age Ageing 2019 Jul."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib119","doi-asserted-by":"crossref","first-page":"85","DOI":"10.11005\/jbm.2020.27.2.85","article-title":"Measurement and interpretation of handgrip strength for research on sarcopenia and osteoporosis","volume":"27","author":"Lee","year":"2020","journal-title":"J. Bone Metab."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib120","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1186\/s12877-024-05569-y","article-title":"Diagnostic accuracy of isometric knee extension strength as a sarcopenia criteria in older women","volume":"24","author":"P\u00e9rez-Ros","year":"2024","journal-title":"BMC Geriatr."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib121","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jcsm.13441","article-title":"The optimal cut-off value of five-time chair stand test for assessing sarcopenia among Chinese community-dwelling older adults","volume":"15","author":"Li","year":"2024","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.phrs.2025.107927_bib122","doi-asserted-by":"crossref","first-page":"369","DOI":"10.6061\/clinics\/2015(05)11","article-title":"Accuracy of the timed up and go test for predicting sarcopenia in elderly hospitalized patients","volume":"70","author":"Martinez","year":"2015","journal-title":"Clinics"},{"issue":"12","key":"10.1016\/j.phrs.2025.107927_bib123","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.clnu.2023.10.010","article-title":"The impact of prolonged fasting on 24h energy metabolism and its 24h rhythmicity in healthy, lean males: a randomized cross-over trial","volume":"42","author":"Andriessen","year":"2023","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib124","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41467-024-55418-0","article-title":"Effects of seven days\u2019 fasting on physical performance and metabolic adaptation during exercise in humans","volume":"16","author":"Kolnes","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib125","doi-asserted-by":"crossref","DOI":"10.1093\/lifemeta\/load014","article-title":"Weight loss increases skeletal muscle mitochondrial energy efficiency in obese mice","volume":"2","author":"Ferrara","year":"2023","journal-title":"Life Metab."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib126","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12933-023-02059-0","article-title":"Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004\u20132015 cohort studies: no obesity paradox?","volume":"22","author":"Osadnik","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib127","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeac039","article-title":"The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events","volume":"2","author":"Maierean","year":"2022","journal-title":"Eur. Heart J. Open"},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/ejendo\/lvad122","article-title":"Identification of myokines susceptible to improve glucose homeostasis after bariatric surgery","volume":"189","author":"Orioli","year":"2023","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib129","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13370","article-title":"The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: a systematic review and meta-analysis","volume":"23","author":"Nuijten","year":"2022","journal-title":"Obes. Rev."},{"key":"10.1016\/j.phrs.2025.107927_bib130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2147\/DMSO.S443631","article-title":"Assessment of changes in body composition after 3 months of dulaglutide treatment","volume":"17","author":"Chen","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib131","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3803\/EnM.2019.34.3.247","article-title":"A review of the effects of Glucagon-Like Peptide-1 receptor agonists and Sodium-Glucose cotransporter 2 inhibitors on lean body mass in humans","volume":"34","author":"Sargeant","year":"2019","journal-title":"Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.phrs.2025.107927_bib132","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2213-8587(24)00272-9","article-title":"Muscle matters: the effects of medically induced weight loss on skeletal muscle","volume":"12","author":"Prado","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"8","key":"10.1016\/j.phrs.2025.107927_bib133","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jdiacomp.2018.05.018","article-title":"The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis","volume":"32","author":"Yajima","year":"2018","journal-title":"J. Diabetes Complicat."},{"issue":"9","key":"10.1016\/j.phrs.2025.107927_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119300","article-title":"GLP-1 regulates exercise endurance and skeletal muscle remodeling via GLP-1R\/AMPK pathway","volume":"1869","author":"Wu","year":"2022","journal-title":"Biochim Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.phrs.2025.107927_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102479","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin","volume":"89","author":"Chan","year":"2024","journal-title":"Tissue Cell"},{"key":"10.1016\/j.phrs.2025.107927_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154044","article-title":"Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents","volume":"103","author":"Gurjar","year":"2020","journal-title":"Metabolism"},{"issue":"18","key":"10.1016\/j.phrs.2025.107927_bib137","doi-asserted-by":"crossref","first-page":"21962","DOI":"10.18632\/aging.203546","article-title":"Dulaglutide improves muscle function by attenuating inflammation through OPA-1-TLR-9 signaling in aged mice","volume":"13","author":"Khin","year":"2021","journal-title":"Aging"},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib138","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/jcsm.12434","article-title":"Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy","volume":"10","author":"Hong","year":"2019","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.phrs.2025.107927_bib139","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.2147\/DDDT.S381546","article-title":"An effective Glucagon-Like Peptide-1 receptor agonists, semaglutide, improves sarcopenic obesity in obese mice by modulating skeletal muscle metabolism","volume":"16","author":"Ren","year":"2022","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.phrs.2025.107927_bib140","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9926462","article-title":"Dulaglutide protects mice against diabetic Sarcopenia-Mediated muscle injury by inhibiting inflammation and regulating the differentiation of myoblasts","volume":"2023","author":"Deng","year":"2023","journal-title":"Int J. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib141","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13677","article-title":"The effects of Glucagon-Like Peptide-1 receptor agonists on mitochondrial function within skeletal muscle: a systematic review","volume":"16","author":"Old","year":"2025","journal-title":"J. Cachex.. Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2025.108975","article-title":"Liraglutide improves senescence and ameliorating diabetic sarcopenia via the YAP-TAZ pathway","volume":"39","author":"Xu","year":"2025","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.phrs.2025.107927_bib143","doi-asserted-by":"crossref","DOI":"10.1093\/bbb\/zbaf060","article-title":"Liraglutide enhances myotube differentiation and muscle contractile activity upon electric pulse stimulation in mouse skeletal muscle cells","author":"Mukai","year":"2025","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.phrs.2025.107927_bib144","article-title":"Semaglutide-induced weight loss improves mitochondrial energy efficiency in skeletal muscle","author":"Choi","year":"2024","journal-title":"bioRxiv [Preprint]"},{"key":"10.1016\/j.phrs.2025.107927_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111472","article-title":"Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats","volume":"539","author":"Yamada","year":"2022","journal-title":"Mol. Cell Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib146","first-page":"98","article-title":"Skeletal muscle mass and body weight fall proportionally with use of dual GLP-1\/GIP receptor agonist tirzepatide: case report and review of literature","volume":"11","author":"Zinn","year":"2024","journal-title":"AACE Clin. Case Rep."},{"key":"10.1016\/j.phrs.2025.107927_bib147","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/DMSO.S425642","article-title":"GLP-1RA liraglutide and semaglutide improves Obesity-Induced muscle atrophy via SIRT1 pathway","volume":"16","author":"Xiang","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib148","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41598-022-05323-7","article-title":"Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis","volume":"12","author":"Meurot","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib149","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2012.07.086","article-title":"Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation","volume":"425","author":"Shiraishi","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pharep.2015.10.008","article-title":"Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes\/macrophages in a protein kinase a and B\/Akt manner","volume":"68","author":"Bu\u0142dak \u0141","year":"2016","journal-title":"Pharm. Rep."},{"issue":"12","key":"10.1016\/j.phrs.2025.107927_bib151","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20165826","article-title":"Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages","volume":"49","author":"Guo","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"7","key":"10.1016\/j.phrs.2025.107927_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166770","article-title":"Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice","volume":"1869","author":"Iwai","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"16","key":"10.1016\/j.phrs.2025.107927_bib153","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.124.067676","article-title":"Muscle mass and Glucagon-Like Peptide-1 receptor agonists: adaptive or maladaptive response to weight loss?","volume":"150","author":"Linge","year":"2024","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.phrs.2025.107927_bib154","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jdiacomp.2016.07.020","article-title":"Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes","volume":"30","author":"Liu","year":"2016","journal-title":"J. Diabetes Complicat."},{"issue":"11","key":"10.1016\/j.phrs.2025.107927_bib155","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.numecd.2021.07.015","article-title":"Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus","volume":"31","author":"Guarnotta","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib156","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12933-025-02607-w","article-title":"The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF)","volume":"24","author":"Hullon","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib157","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/jcsm.13445","article-title":"Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: results from a randomized clinical trial","volume":"15","author":"Pandey","year":"2024","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.phrs.2025.107927_bib158","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S2213-8587(25)00027-0","article-title":"Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial","volume":"13","author":"Sattar","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib159","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/dom.16162","article-title":"Weight loss and body composition after compounded semaglutide treatment in a real world setting","volume":"27","author":"Chun","year":"2025","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/cid\/ciae384","article-title":"Effects of semaglutide on muscle structure and function in the SLIM LIVER study","volume":"80","author":"Ditzenberger","year":"2025","journal-title":"Clin. Infect. Dis."},{"issue":"23","key":"10.1016\/j.phrs.2025.107927_bib161","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038444","article-title":"Favorable liver and skeletal muscle changes in patients with MASLD and T2DM receiving glucagon-like peptide-1 receptor agonist: a prospective cohort study","volume":"103","author":"Kakegawa","year":"2024","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.phrs.2025.107927_bib162","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.31805","article-title":"Intrapatient changes in CT-Based body composition after initiation of semaglutide (Glucagon-Like Peptide-1 Receptor Agonist) therapy","volume":"223","author":"Nelson","year":"2024","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.phrs.2025.107927_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1386542","article-title":"Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus","volume":"15","author":"Rodr\u00edguez Jim\u00e9nez","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.phrs.2025.107927_bib164","doi-asserted-by":"crossref","first-page":"377","DOI":"10.14740\/jocmr4987","article-title":"Oral semaglutide induces loss of body fat mass without affecting muscle mass in patients with type 2 diabetes","volume":"15","author":"Uchiyama","year":"2023","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.phrs.2025.107927_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1240263","article-title":"Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study","volume":"14","author":"Volpe","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"20","key":"10.1016\/j.phrs.2025.107927_bib166","first-page":"9908","article-title":"Clinical effectiveness of semaglutide on weight loss, body composition, and muscle strength in Chinese adults","volume":"27","author":"Xiang","year":"2023","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2025.107927_bib167","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/medicines9090047","article-title":"The effectiveness of GLP-1 receptor agonist semaglutide on body composition in elderly obese diabetic patients: a pilot study","volume":"9","author":"Ozeki","year":"2022","journal-title":"Medicines"},{"issue":"12","key":"10.1016\/j.phrs.2025.107927_bib168","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.3390\/nu14122414","article-title":"Once-Weekly semaglutide induces an early improvement in body composition in patients with type 2 diabetes: a 26-Week prospective Real-Life study","volume":"14","author":"Volpe","year":"2022","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.phrs.2025.107927_bib169","first-page":"982","article-title":"The effects of liraglutide on body composition and muscle strength in adult obese patients with type 2 diabetes mellitus","volume":"60","author":"Yu","year":"2021","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"6","key":"10.1016\/j.phrs.2025.107927_bib170","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40520-015-0525-y","article-title":"Liraglutide and obesity in elderly: efficacy in fat loss and safety in order to prevent sarcopenia. A perspective case series study","volume":"28","author":"Perna","year":"2016","journal-title":"Aging Clin. Exp. Res."},{"issue":"6","key":"10.1016\/j.phrs.2025.107927_bib171","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/oby.22794","article-title":"Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5","volume":"28","author":"Kushner","year":"2020","journal-title":"Obesity"},{"issue":"18","key":"10.1016\/j.phrs.2025.107927_bib172","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1056\/NEJMoa2028198","article-title":"Healthy weight loss maintenance with exercise, liraglutide, or both combined","volume":"384","author":"Lundgren","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2025.107927_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111561","article-title":"Aging, obesity, sarcopenia and the effect of diet and exercise intervention","volume":"155","author":"Colleluori","year":"2021","journal-title":"Exp. Gerontol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib174","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.beem.2007.04.007","article-title":"Sexual dimorphism of body composition","volume":"21","author":"Wells","year":"2007","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2025.107927_bib175","doi-asserted-by":"crossref","unstructured":"Janssen I., Heymsfield S.B., Wang Z.M., Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18\u201388\u2009yr. J Appl Physiol (1985). 2000 Jul;89(1):81-88. doi: 10.1152\/jappl.2000.89.1.81. Erratum in: J Appl Physiol (1985). 2014 May 15;116(10):1342. PMID: 10904038.","DOI":"10.1152\/jappl.2000.89.1.81"},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib176","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/jpm12030454","article-title":"Sex differences in response to treatment with Glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care","volume":"12","author":"Rentzeperi","year":"2022","journal-title":"J. Pers. Med."},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib177","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70063","article-title":"Sex differences in the efficacy of Glucagon-Like Peptide-1 receptor agonists for weight reduction: a systematic review and Meta-Analysis","volume":"17","author":"Yang","year":"2025","journal-title":"J. Diabetes"},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib178","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae165","article-title":"GLP-1 and its analogs: does sex matter?","volume":"166","author":"B\u00f6rchers","year":"2025","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2025.107927_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111689","article-title":"M. Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists","volume":"212","author":"Piccini","year":"2024","journal-title":"Diabetes Res. Clin. Pr."},{"issue":"10","key":"10.1016\/j.phrs.2025.107927_bib180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"10.1016\/j.phrs.2025.107927_bib181","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"STEP 1 study group. Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib182","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"SURMOUNT-1 investigators. Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib183","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010145","article-title":"Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus","volume":"12","author":"Gorgojo-Martinez","year":"2022","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib184","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle-Organ crosstalk: the emerging roles of myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocr. Rev."},{"issue":"20","key":"10.1016\/j.phrs.2025.107927_bib185","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMoa1616338","article-title":"Aerobic or resistance exercise, or both, in dieting obese older adults","volume":"376","author":"Villareal","year":"2017","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2025.107927_bib186","series-title":"Preserving musculoskeletal health through resistance training in individuals undergoing Glucagon-like Peptide-1 Receptor Agonist Therapy: a controlled interrupted time-series analysis","author":"Steele","year":"2025"},{"key":"10.1016\/j.phrs.2025.107927_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117207","article-title":"The communication mechanism of the gut-brain axis and its effect on central nervous system diseases: a systematic review","volume":"178","author":"Lu","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"23","key":"10.1016\/j.phrs.2025.107927_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/nu16234032","article-title":"Myokines and microbiota: new perspectives in the endocrine Muscle-Gut axis","volume":"16","author":"Saponaro","year":"2024","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.phrs.2025.107927_bib189","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S2095-4964(17)60342-X","article-title":"Exercise and gut microbiota: clinical implications for the feasibility of tai chi","volume":"15","author":"Hamasaki","year":"2017","journal-title":"J. Integr. Med"},{"issue":"7","key":"10.1016\/j.phrs.2025.107927_bib190","doi-asserted-by":"crossref","DOI":"10.3390\/nu16071070","article-title":"Effects of exercise on gut microbiota of adults: a systematic review and Meta-Analysis","volume":"16","author":"Min","year":"2024","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.phrs.2025.107927_bib191","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11154-014-9288-6","article-title":"Gut microbiota and GLP-1","volume":"15","author":"Everard","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib192","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02032-23","article-title":"Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases","volume":"15","author":"Zeng","year":"2024","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.phrs.2025.107927_bib193","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.2513","article-title":"Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from l cells and alpha cells","volume":"17","author":"Ellingsgaard","year":"2011","journal-title":"Nat. Med"},{"issue":"8","key":"10.1016\/j.phrs.2025.107927_bib194","doi-asserted-by":"crossref","DOI":"10.3390\/nu17081303","article-title":"Effects of GLP-1 analogues and agonists on the gut microbiota: a systematic review","volume":"17","author":"Gofron","year":"2025","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.phrs.2025.107927_bib195","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0002-8223(02)90346-9","article-title":"Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids","volume":"102","author":"Trumbo","year":"2002","journal-title":"J. Am. Diet. Assoc."},{"issue":"2","key":"10.1016\/j.phrs.2025.107927_bib196","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.soard.2019.10.025","volume":"16","author":"Mechanick","year":"2020","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.phrs.2025.107927_bib197","article-title":"Dietary intake by patients taking GLP-1 and dual GIP\/GLP-1 receptor agonists: a narrative review and discussion of research needs","volume":"11","author":"Christensen","year":"2024","journal-title":"Obes. Pillars"},{"issue":"1","key":"10.1016\/j.phrs.2025.107927_bib198","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: a phase 2 randomized clinical trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw. Open"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:14:53Z","timestamp":1758590093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825003524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":198,"alternative-id":["S1043661825003524"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107927","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonists and muscle mass effects","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107927"}}